ARMSTRONG SHAW ASSOCIATES INC/CT recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
237 ELM ST NEW CANAAN, CT 06840
As of the latest 13F report, the guru’s equity portfolio contained 42 stocks valued at a total of $101.00Mil. The top holdings were MSFT(10.12%), BRK.A(9.32%), and UNH(7.59%).
According to GuruFocus data, these were ARMSTRONG SHAW ASSOCIATES INC/CT’s top five trades of the quarter.
iShares MSCI Emerging Markets ETF
The guru sold out of their 9,500-share investment in ARCA:EEM. Previously, the stock had a 0.36% weight in the equity portfolio. Shares traded for an average price of $36.46 during the quarter.
On 02/07/2023, iShares MSCI Emerging Markets ETF traded for a price of $40.145 per share and a market cap of $25.60Bil. The stock has returned -15.13% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
In terms of valuation, iShares MSCI Emerging Markets ETF has a price-earnings ratio of 10.95 and a price-book ratio of 1.63.
Microsoft Corp
ARMSTRONG SHAW ASSOCIATES INC/CT reduced their investment in NAS:MSFT by 1,213 shares. The trade had a 0.3% impact on the equity portfolio. During the quarter, the stock traded for an average price of $239.99.
On 02/07/2023, Microsoft Corp traded for a price of $263.1381 per share and a market cap of $1,958.75Bil. The stock has returned -11.97% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Microsoft Corp has a price-earnings ratio of 29.24, a price-book ratio of 10.70, a price-earnings-to-growth (PEG) ratio of 1.42, a EV-to-Ebitda ratio of 18.97 and a price-sales ratio of 9.66.
The price-to-GF Value ratio is 0.84, earning the stock a GF Value rank of 9.
The Walt Disney Co
The guru sold out of their 2,610-share investment in NYSE:DIS. Previously, the stock had a 0.26% weight in the equity portfolio. Shares traded for an average price of $95.65000000000001 during the quarter.
On 02/07/2023, The Walt Disney Co traded for a price of $109.53 per share and a market cap of $200.09Bil. The stock has returned -23.40% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, The Walt Disney Co has a price-earnings ratio of 63.68, a price-book ratio of 2.05, a EV-to-Ebitda ratio of 20.08 and a price-sales ratio of 2.43.
The price-to-GF Value ratio is 0.67, earning the stock a GF Value rank of 8.
Gilead Sciences Inc
The guru established a new position worth 2,950 shares in NAS:GILD, giving the stock a 0.25% weight in the equity portfolio. Shares traded for an average price of $79.19 during the quarter.
On 02/07/2023, Gilead Sciences Inc traded for a price of $85.94 per share and a market cap of $107.17Bil. The stock has returned 39.13% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Gilead Sciences Inc has a price-earnings ratio of 23.55, a price-book ratio of 5.08, a EV-to-Ebitda ratio of 15.28 and a price-sales ratio of 3.97.
The price-to-GF Value ratio is 1.19, earning the stock a GF Value rank of 3.
Zimmer Biomet Holdings Inc
The guru established a new position worth 1,900 shares in NYSE:ZBH, giving the stock a 0.24% weight in the equity portfolio. Shares traded for an average price of $116.05 during the quarter.
On 02/07/2023, Zimmer Biomet Holdings Inc traded for a price of $129.3954 per share and a market cap of $27.15Bil. The stock has returned 19.58% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Zimmer Biomet Holdings Inc has a price-earnings ratio of 75.23, a price-book ratio of 2.26, a EV-to-Ebitda ratio of 21.68 and a price-sales ratio of 3.93.
The price-to-GF Value ratio is 1.12, earning the stock a GF Value rank of 5.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
